XStocksXray

Research report · 16 October 2026

Albemarle Corp (ALB)

Materials · Specialty Chemicals · US stock · price as of 16 Oct 2026

Key indicators

Price	$95.48
52-week range	$87.01 – $219.70
Market cap	$13.0B
P/E (trailing)	52.2×
EV / EBITDA	14.8×
Free-cash-flow yield	10.3%
Dividend yield	1.7%
Revenue (last 12 months)	$5.9B
Revenue growth (3y a year)	−11.1%
Operating margin	4.3%
Return on invested capital	1.7%
Net debt / EBITDA	0.4×

Fair value

Blended fair value$60.58 range $58 – $63

Versus priceData under review+0% to fair value

Peer multiples	$65.47
Fundamentals-adjusted multiple	$75.12
10-year DCF (market-scaled)	$41.14
Earnings power value (floor, not blended)	$23.82
Model uncertainty	High

X-Ray Score

41/ 100 · High confidence · ahead of 22% of sector peers

Valuation39

Growth17

Profitability29

Financial health71

Dividends61

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

Executive summary

Albemarle is a specialty chemicals company centred on lithium, bromine and catalysts. Lithium compounds go to makers of batteries for electric vehicles and energy storage, bromine products serve fire-safety and electronics uses, and catalysts are supplied to oil refiners. The business is organised around energy storage, specialties and catalyst operations, and its customers are mostly industrial and manufacturing companies.

Earnings move with demand in end markets such as electric vehicles and with the volumes of chemicals supplied. Revenue is $5.9 billion over the last twelve months, but revenue growth over three years is -11.1% a year. The operating margin is 4.3%, and the business earns a profit of 2% on the capital invested in it. Albemarle carries net debt of 0.4 times EBITDA, and the dividend yield is 1.7%.

StocksXray gives Albemarle Corp an X-Ray Score of 41 out of 100 (high confidence), ahead of 22% of the S&P 500 stocks in its sector. Its strongest lens is financial health (71) and its weakest is growth (17).

Our fair value blend is $60.58 (range $58.15 to $63.40). At $95.48 the stock trades 58% above that blend, so the label is "Data under review" with high model uncertainty. Fair value is a range, not a price target.

XStocksXray

Albemarle Corp (ALB)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

	FY2021	FY2022	FY2023	FY2024	FY2025	Now
Price	$220.27	$205.67	$138.22	$83.63	$140.26	$95.48
Market cap	$25.7B	$24.2B	$16.3B	$9.8B	$16.5B	$13.0B
P/E	207.8×	9.0×	10.3×	–	–	52.2×
EV / revenue	8.4×	3.6×	2.1×	2.3×	3.6×	2.3×
EV / EBITDA	26.4×	9.4×	29.1×	–	62.9×	15.1×
Price / free cash flow	–	37.2×	–	–	23.8×	9.7×
Free-cash-flow yield	−2.4%	2.7%	−5.1%	−10.1%	4.2%	10.3%
Price / book	4.6×	3.0×	1.7×	1.0×	1.7×	1.3×
Dividend yield	0.71%	0.77%	1.16%	1.93%	1.15%	1.70%

Fundamentals checklist ● 6 Good · ● 2 Average · ● 7 Bad · each check graded against the sector

Cash quality

Earnings backed by cash−9.9%Good

Free-cash-flow yield10.3%Good

Risk models

Altman Z score3.9×Good

Piotroski F-Score6 of 9Average

Growth

Free-cash-flow growth (3y)2.1%Average

Revenue growth (3y)−11.1%Bad

Growth consistency30%Bad

Balance sheet

Current ratio2.1×Good

Net debt / EBITDA0.4×Good

Interest coverno interest costGood

Valuation

Fair value vs price0.6×Bad

EBIT / EV yield1.8%Bad

Profitability

Return on invested capital1.7%Bad

Operating margin4.3%Bad

Gross profitability8.8%Bad

XStocksXray

Albemarle Corp (ALB)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statement	FY21	FY22	FY23	FY24	FY25	LTM
Revenue	3,328	7,320	9,617	5,378	5,143	5,908
Gross profit	998	3,075	1,186	63	669	1,407
Operating income	798	2,470	252	-1,777	-367	252
Net income	124	2,690	1,573	-1,179	-511	224
Diluted EPS ($)	1.06	22.84	13.36	-11.20	-5.76	1.83
Free cash flow	-609	651	-828	-993	692	1,342
Gross margin	30.0%	42.0%	12.3%	1.2%	13.0%	23.8%
Operating margin	24.0%	33.7%	2.6%	−33.0%	−7.1%	4.3%
Net margin	3.7%	36.7%	16.4%	−21.9%	−9.9%	3.8%
Balance sheet	FY21	FY22	FY23	FY24	FY25	LTM
Total assets	10,974	15,457	18,271	16,610	16,374	15,905
Cash	439	1,499	890	1,192	1,618	1,632
Total debt	2,394	3,217	4,167	3,516	3,194	1,877
Equity	5,625	7,983	9,412	9,962	9,533	10,275
Dividend per share ($)	1.56	1.58	1.60	1.61	1.62	1.62

Revenue and net income US$ billions: navy revenue, teal net income

Margins blue gross, teal operating, brown net

Latest quarters

	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue ($M)	1,077	1,330	1,308	1,428	1,429	1,743
Growth vs a year earlier	−20.9%	−7.0%	−3.5%	+15.9%	+32.7%	+31.1%
Net income ($M)	41	23	-161	-414	319	480
Diluted EPS ($)	0.00	-0.16	-1.72	–	2.34	3.52

XStocksXray

Albemarle Corp (ALB)

Peers in Specialty Chemicals

Company	X-Ray
ALB · Albemarle Corp	41
PPG · Ppg Industries Inc	66
SHW · Sherwin Williams Co	57
ECL · Ecolab Inc.	50
IFF · International Flavors & Fr...	23

Market Compass outlook for Materials: Neutral (50/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week	−5.7%
1 month	−17.0%
3 months	−18.9%
6 months	−51.4%
1 year	−1.6%
3 years	−39.3%
5 years	−52.8%

Technical summary

DailyBearish4 bullish · 0 neutral · 12 bearish

WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish

MonthlyStrongly bearish1 bullish · 1 neutral · 6 bearish

50-day / 200-day average	$119.17 / $152.41
52-week low / high	$87.01 / $219.70
Classic pivot, support and resistance	S2 92.06 · S1 93.77 · P – · R1 98.09 · R2 100.70

Recent dividends

Ex-dividend date	Amount per share
11 Sep 2026	$0.4100
12 Jun 2026	$0.4050
13 Mar 2026	$0.4050
12 Dec 2025	$0.4050
12 Sep 2025	$0.4050
13 Jun 2025	$0.4050

XStocksXray

Albemarle Corp (ALB)

Strengths

Free-cash-flow yield of 10.3% is ahead of 98% of its sector peers.
Interest cover of no interest cost is ahead of 91% of its sector peers.
Net debt is only 0.4× EBITDA, ahead of 85% of its sector peers.
Piotroski F-Score of 6 out of 9: most of the nine accounting health tests pass.
Has raised its dividend for 7 years in a row.

Risks and weak spots

Revenue growth (3y) is weak against Materials peers (−11.1%).
Growth consistency is weak against Materials peers (30%).
Fair value vs price is weak against Materials peers (0.6×).
EBIT / EV yield is weak against Materials peers (1.8%).
Return on invested capital is weak against Materials peers (1.7%).
Operating margin is weak against Materials peers (4.3%).
Gross profitability is weak against Materials peers (8.8%).

Latest SEC filings

Date	Form	Items
3 Sep 2026	8-K	5.02,7.01,9.01
21 Aug 2026	8-K	5.02
5 Aug 2026	10-Q
5 Aug 2026	8-K	2.02,9.01
23 Jul 2026	8-K	5.02,7.01,9.01
5 Jun 2026	8-K	5.02
8 May 2026	8-K	5.02,5.07,9.01
6 May 2026	10-Q

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.